1158:
1147:
22:
90:
241:
363:
and engages other companies to further develop them into commercializable drugs. The company entered into its first major commercialization agreement in 2009 when it partnered with Ikaria
Holdings Inc. to develop its BL-1040 compound. In 2010, BioLine entered into a commercialization agreement with
1113:
349:
606:
Bioline
Therapeutics today pulled off its initial public offering in Tel Aviv, raising NIS 211 million at a company valuation of NIS 494 million, making this the biggest flotation by a biotechnology company in local
307:
began trading on the NASDAQ Capital Market. In
January 2012, the firm announced a deal with Genoscience, a French pharmaceutical company to jointly develop and market the BL-8020 compound, as a treatment for
1533:
702:
1030:
636:
BioLineRx Ltd. on
Wednesday priced the largest ever initial public offering of a biomedical company on the Tel Aviv Stock Exchange, raising a total of NIS 211 million, or $ 50m.
1538:
126:
484:
810:
679:
893:
1543:
922:
777:
746:
364:
Cypress
Bioscience Inc. for development of its BL-1020 compound. The agreement with Cypress was canceled in 2011 when the company was taken over by
1108:
954:
1548:
1135:
1558:
1003:
588:
842:
706:
980:
555:
1062:
1040:
1035:
1103:
534:
1553:
1502:
1378:
1328:
860:
69:
292:
51:
32:
1323:
1282:
450:
288:
648:
1128:
428:
418:
304:
1465:
1414:
1353:
1333:
1272:
1189:
539:
1063:"BioLineRx signs pact with Genoscience & RFS Pharma to develop and commercialize BL-8030 to treat hepatitis C"
932:
820:
787:
1267:
720:
360:
329:
47:
894:"BioLineRx Announces Positive Preliminary Results from Phase I Clinical Trial of BL-1021 for Neuropathic Pain"
865:
384:. Unless indicated otherwise, they have not obtained regulatory approval in relation to the diseases cited.
333:
296:
276:
186:
122:
1121:
754:
442:
1318:
422:
272:
671:
1486:
1237:
435:
1445:
1429:
359:
is a drug development company When promising compounds are discovered, the firm leads them through
337:
182:
1460:
927:
815:
782:
724:
620:
560:
300:
846:
988:
1070:
479:
340:
early in 2010. Savitsky was replaced as CEO by BioLine COO Philip Serlin on
October 10, 2016.
565:
1470:
1297:
1277:
1252:
1214:
1074:
412:
389:
377:
317:
197:
1219:
467:
456:
256:
303:($ 50 million) โ the TASE's largest biotech IPO until that time. In July 2011 BioLine's
1409:
1383:
1368:
1199:
1008:
508:
408:
268:
100:
43:
320:
in the company as a strategic move to gain access to
Israeli-sourced drug candidates.
1527:
1507:
1450:
1194:
1157:
908:
446:
402:
136:
118:
108:
1363:
1039:. The Edmond and Lily Safra Center for Brain Sciences. 27 June 2011. Archived from
1031:"BioLineRx has acquired the rights to compound BL-7040 from Yissum and Prof. Soreq"
955:"US company buys exclusive license for Israeli heart attack drug for $ 285 million"
503:
309:
271:
drug development company. Headquartered in Israel, its shares are traded on the
245:
1404:
1287:
1247:
1204:
1424:
1292:
1262:
897:
870:
593:
89:
861:"Israeli co to hold clinical trial for treatment of Schizophrenia in India"
336:
of BioLineRx until 2009. He was replaced by
Kinneret Savitsky, alumnus of
1419:
1358:
1343:
1338:
1302:
1242:
1183:
463:
313:
207:
843:"BioLineRx In-Licenses Novel Compound for Treatment of Neuropathic Pain"
589:"Biotech comes of age: Bioline floats at half-billion shekel market cap"
240:
1512:
1388:
1373:
1257:
1173:
394:
455:
BL-8020 โ orally administered treatment for
Hepatitis C, developed by
348:
1455:
1348:
1209:
1152:
1146:
299:
on the Tel Aviv Stock
Exchange in February 2007, raising 211 million
165:
114:
721:"Kinneret Livnat Savitsky Ph.D.: Executive Profile & Biography"
1098:
703:"Achillion, BioLineRx, J&J Snack, Rubicon: U.S. Equity Movers"
347:
239:
398:
1117:
1004:"Bioline RX Gets European Device Confirmation for Bl-5010 Drug"
376:
Below is a partial list of drug compounds in various stages of
15:
811:"BiolineRX and Cypress cancel schizophrenia drug agreement"
219:
621:"BioLineRx raises $ 50m. in TASE's largest biomedical IPO"
466:
inhibitor for oral treatment of Hepatitis C, invented by
923:"Bioline looks to heart attack treatment clinical trial"
543:. Vol. 35, no. 2. 16 December 2014. p. 9.
287:
The firm was established in 2003 as a joint venture of
39:
295:, Yehuda Zisapel, and other investors. It executed an
670:
Cohen, Tova (24 July 2011). Magnowski, Daniel (ed.).
417:
BL-1040 โ liquid polymer injected into patients with
427:
BL-1230 - a selective cannabinoid receptor type 2 (
50:, and by adding encyclopedic content written from a
1495:
1479:
1438:
1397:
1311:
1228:
1166:
214:
203:
193:
176:
160:
142:
132:
106:
96:
672:"BioLineRX ADRs to begin trading on Nasdaq Monday"
1534:Companies listed on the Tel Aviv Stock Exchange
535:"Novartis Makes $ 10M Investment in BioLineRx"
485:List of Israeli companies quoted on the Nasdaq
1129:
8:
540:Genetic Engineering & Biotechnology News
529:
527:
82:
1539:Biotechnology companies established in 2003
1136:
1122:
1114:
556:"BioLineRx signs 3 deals to develop drugs"
459:, co-founder and President of Genoscience.
88:
81:
778:"BiolineRX earns $ 10m milestone payment"
401:-enhanced antipsychotic for treatment of
70:Learn how and when to remove this message
747:"BioLineRxโIsrael's biotech supermarket"
649:"BioLineRx ADRs Begin Trading on NASDAQ"
1109:Office of the Chief Scientist of Israel
776:Habib-Valdhorn, Shiri (28 April 2010).
495:
682:from the original on 24 September 2015
619:Rheinheimer, Laura (8 February 2007).
31:contains content that is written like
431:) agonist for Dry Eye Syndrome (DES)
328:Morris Laster, (M.D.) an alumnus of.
7:
1002:Wrobel, Sharon (15 September 2011).
504:"BLRX Profile: BioLineRx Ltd. Stock"
260:
1036:The Hebrew University of Jerusalem
931:. 27 February 2011. Archived from
554:Grayeff, Yigal (13 January 2005).
14:
1544:Biotechnology companies of Israel
1503:Ampal-American Israel Corporation
1379:Sapiens International Corporation
1329:Check Point Software Technologies
1073:. 8 February 2012. Archived from
1156:
1145:
705:. Bloomberg News. Archived from
576:– via IVC Research Center.
462:BL-8030 โ second-generation NS3
20:
1104:Jerusalem Development Authority
892:BioLineRx (13 September 2011).
587:Cohen, Omri (7 February 2007).
293:Jerusalem Development Authority
232:Footnotes / references
1549:Companies listed on the Nasdaq
1324:B.O.S. Better Online Solutions
1283:Partner Communications Company
451:Hebrew University of Jerusalem
434:BL-5010 โ cream treatment for
421:, invented by Smadar Cohen of
1:
1559:2003 establishments in Israel
809:Weinreb, Gali (11 May 2011).
1151:Israeli companies traded on
745:Brinn, David (3 June 2007).
701:Wang, Lu (24 January 2012).
291:, Hadasit Bio-Holdings, the
1456:Ituran Location and Control
441:BL-7040 โ orally available
419:acute myocardial infarction
407:BL-1021 โ orally available
388:BL-1010 โ orally available
148:; 21 years ago
1575:
1466:RADA Electronic Industries
1415:Nova Measuring Instruments
1354:Magic Software Enterprises
1334:ClickSoftware Technologies
1273:Internet Gold Golden Lines
248:Technology Park, Jerusalem
230:
87:
1554:Drug discovery companies
1268:Gilat Satellite Networks
330:Downstate Medical Center
866:The Hindu Business Line
297:initial public offering
277:Tel Aviv Stock Exchange
1439:Security & defense
443:anti-inflammatory drug
353:
312:. At the end of 2014,
249:
1319:BluePhoenix Solutions
1278:Orckit Communications
423:Ben-Gurion University
351:
273:NASDAQ Capital Market
243:
52:neutral point of view
1487:Caesarstone Sdot-Yam
1238:Allot Communications
436:seborrheic keratosis
244:BioLineRX office in
1430:Tower Semiconductor
1229:Communication &
1077:on 21 February 2015
709:on 24 January 2012.
397:โ orally available
338:Tel Aviv University
84:
44:promotional content
1461:Pointer Telocation
873:. 24 November 2011
725:Bloomberg Business
625:The Jerusalem Post
568:on 3 February 2010
561:The Jerusalem Post
537:. Industry Watch.
361:preclinical trials
354:
250:
46:and inappropriate
1521:
1520:
1071:Jerusalem, Israel
985:www.biolinerx.com
896:(Press release).
480:TA BlueTech Index
411:for treatment of
316:acquired a 12.8%
283:Corporate history
238:
237:
80:
79:
72:
1566:
1471:TAT Technologies
1298:RiT Technologies
1258:Ceragon Networks
1253:B Communications
1215:Rosetta Genomics
1161:
1160:
1150:
1149:
1138:
1131:
1124:
1115:
1087:
1086:
1084:
1082:
1059:
1053:
1052:
1050:
1048:
1027:
1021:
1020:
1018:
1016:
999:
993:
992:
987:. Archived from
977:
971:
970:
968:
966:
951:
945:
944:
942:
940:
935:on 3 August 2012
919:
913:
912:
906:
904:
889:
883:
882:
880:
878:
857:
851:
850:
845:. Archived from
839:
833:
832:
830:
828:
819:. Archived from
806:
800:
799:
797:
795:
790:on 3 August 2012
786:. Archived from
773:
767:
766:
764:
762:
753:. Archived from
742:
736:
735:
733:
731:
717:
711:
710:
698:
692:
691:
689:
687:
667:
661:
660:
658:
656:
645:
639:
638:
633:
631:
616:
610:
609:
603:
601:
584:
578:
577:
575:
573:
564:. Archived from
551:
545:
544:
531:
522:
521:
519:
517:
500:
413:neuropathic pain
390:neuropathic pain
262:
226:
223:
221:
198:Drug development
156:
154:
149:
92:
85:
75:
68:
64:
61:
55:
33:an advertisement
24:
23:
16:
1574:
1573:
1569:
1568:
1567:
1565:
1564:
1563:
1524:
1523:
1522:
1517:
1491:
1475:
1434:
1393:
1307:
1230:
1224:
1220:Syneron Medical
1210:Rewalk Robotics
1162:
1155:
1144:
1142:
1095:
1090:
1080:
1078:
1061:
1060:
1056:
1046:
1044:
1043:on 12 July 2011
1029:
1028:
1024:
1014:
1012:
1001:
1000:
996:
979:
978:
974:
964:
962:
953:
952:
948:
938:
936:
921:
920:
916:
902:
900:
891:
890:
886:
876:
874:
859:
858:
854:
841:
840:
836:
826:
824:
823:on 15 June 2011
808:
807:
803:
793:
791:
775:
774:
770:
760:
758:
757:on 5 April 2012
744:
743:
739:
729:
727:
719:
718:
714:
700:
699:
695:
685:
683:
669:
668:
664:
654:
652:
647:
646:
642:
629:
627:
618:
617:
613:
599:
597:
586:
585:
581:
571:
569:
553:
552:
548:
533:
532:
525:
515:
513:
502:
501:
497:
493:
476:
468:Philippe Halfon
457:Philippe Halfon
374:
346:
326:
285:
269:publicly traded
234:
218:
179:
172:
168:
152:
150:
147:
121:
111:
76:
65:
59:
56:
37:
25:
21:
12:
11:
5:
1572:
1570:
1562:
1561:
1556:
1551:
1546:
1541:
1536:
1526:
1525:
1519:
1518:
1516:
1515:
1510:
1505:
1499:
1497:
1493:
1492:
1490:
1489:
1483:
1481:
1480:Consumer goods
1477:
1476:
1474:
1473:
1468:
1463:
1458:
1453:
1448:
1442:
1440:
1436:
1435:
1433:
1432:
1427:
1422:
1417:
1412:
1410:Kornit Digital
1407:
1401:
1399:
1395:
1394:
1392:
1391:
1386:
1384:Verint Systems
1381:
1376:
1371:
1369:Perion Network
1366:
1361:
1356:
1351:
1346:
1341:
1336:
1331:
1326:
1321:
1315:
1313:
1309:
1308:
1306:
1305:
1300:
1295:
1290:
1285:
1280:
1275:
1270:
1265:
1260:
1255:
1250:
1245:
1240:
1234:
1232:
1226:
1225:
1223:
1222:
1217:
1212:
1207:
1202:
1200:Mazor Robotics
1197:
1192:
1187:
1186:Pharmaceutical
1181:
1176:
1170:
1168:
1164:
1163:
1143:
1141:
1140:
1133:
1126:
1118:
1112:
1111:
1106:
1101:
1094:
1093:External links
1091:
1089:
1088:
1054:
1022:
994:
991:on 2016-12-02.
972:
946:
914:
884:
852:
849:on 2015-09-26.
834:
801:
768:
737:
712:
693:
662:
651:. 25 July 2011
640:
611:
579:
546:
523:
509:Yahoo! Finance
494:
492:
489:
488:
487:
482:
475:
472:
471:
470:
460:
453:
439:
432:
425:
415:
409:small molecule
405:
392:
373:
370:
345:
342:
325:
322:
284:
281:
261:ืืืืืืื ืืจ ืืงืก
253:BioLineRx Ltd.
236:
235:
228:
227:
216:
212:
211:
205:
201:
200:
195:
191:
190:
180:
177:
174:
173:
170:
164:
162:
158:
157:
144:
140:
139:
134:
130:
129:
112:
107:
104:
103:
98:
94:
93:
83:BioLineRx Ltd.
78:
77:
48:external links
28:
26:
19:
13:
10:
9:
6:
4:
3:
2:
1571:
1560:
1557:
1555:
1552:
1550:
1547:
1545:
1542:
1540:
1537:
1535:
1532:
1531:
1529:
1514:
1511:
1509:
1508:Elbit Imaging
1506:
1504:
1501:
1500:
1498:
1496:Conglomerates
1494:
1488:
1485:
1484:
1482:
1478:
1472:
1469:
1467:
1464:
1462:
1459:
1457:
1454:
1452:
1451:Elbit Systems
1449:
1447:
1444:
1443:
1441:
1437:
1431:
1428:
1426:
1423:
1421:
1418:
1416:
1413:
1411:
1408:
1406:
1403:
1402:
1400:
1396:
1390:
1387:
1385:
1382:
1380:
1377:
1375:
1372:
1370:
1367:
1365:
1362:
1360:
1357:
1355:
1352:
1350:
1347:
1345:
1342:
1340:
1337:
1335:
1332:
1330:
1327:
1325:
1322:
1320:
1317:
1316:
1314:
1310:
1304:
1301:
1299:
1296:
1294:
1291:
1289:
1286:
1284:
1281:
1279:
1276:
1274:
1271:
1269:
1266:
1264:
1261:
1259:
1256:
1254:
1251:
1249:
1246:
1244:
1241:
1239:
1236:
1235:
1233:
1227:
1221:
1218:
1216:
1213:
1211:
1208:
1206:
1203:
1201:
1198:
1196:
1195:Given Imaging
1193:
1191:
1188:
1185:
1182:
1180:
1177:
1175:
1172:
1171:
1169:
1165:
1159:
1154:
1148:
1139:
1134:
1132:
1127:
1125:
1120:
1119:
1116:
1110:
1107:
1105:
1102:
1100:
1097:
1096:
1092:
1076:
1072:
1068:
1067:Pharmabiz.com
1064:
1058:
1055:
1042:
1038:
1037:
1032:
1026:
1023:
1011:
1010:
1005:
998:
995:
990:
986:
982:
976:
973:
961:. 8 July 2009
960:
956:
950:
947:
934:
930:
929:
924:
918:
915:
910:
909:Business Wire
899:
895:
888:
885:
872:
868:
867:
862:
856:
853:
848:
844:
838:
835:
822:
818:
817:
812:
805:
802:
789:
785:
784:
779:
772:
769:
756:
752:
748:
741:
738:
726:
722:
716:
713:
708:
704:
697:
694:
681:
677:
673:
666:
663:
650:
644:
641:
637:
626:
622:
615:
612:
608:
596:
595:
590:
583:
580:
567:
563:
562:
557:
550:
547:
542:
541:
536:
530:
528:
524:
511:
510:
505:
499:
496:
490:
486:
483:
481:
478:
477:
473:
469:
465:
461:
458:
454:
452:
448:
447:Hermona Soreq
444:
440:
437:
433:
430:
426:
424:
420:
416:
414:
410:
406:
404:
403:schizophrenia
400:
396:
393:
391:
387:
386:
385:
383:
379:
371:
369:
367:
362:
358:
352:Previous logo
350:
343:
341:
339:
335:
331:
323:
321:
319:
315:
311:
306:
302:
298:
294:
290:
282:
280:
278:
274:
270:
266:
258:
254:
247:
242:
233:
229:
225:
217:
213:
210:(12.8%, 2014)
209:
206:
202:
199:
196:
192:
188:
184:
183:Philip Serlin
181:
175:
167:
163:
159:
145:
141:
138:
137:Biotechnology
135:
131:
128:
124:
120:
116:
113:
110:
105:
102:
99:
95:
91:
86:
74:
71:
63:
53:
49:
45:
41:
35:
34:
29:This article
27:
18:
17:
1364:NICE Systems
1178:
1099:BioJerusalem
1079:. Retrieved
1075:the original
1066:
1057:
1045:. Retrieved
1041:the original
1034:
1025:
1013:. Retrieved
1007:
997:
989:the original
984:
975:
963:. Retrieved
958:
949:
937:. Retrieved
933:the original
926:
917:
907:– via
901:. Retrieved
887:
875:. Retrieved
864:
855:
847:the original
837:
825:. Retrieved
821:the original
814:
804:
792:. Retrieved
788:the original
781:
771:
759:. Retrieved
755:the original
750:
740:
728:. Retrieved
715:
707:the original
696:
684:. Retrieved
675:
665:
653:. Retrieved
643:
635:
628:. Retrieved
624:
614:
605:
598:. Retrieved
592:
582:
570:. Retrieved
566:the original
559:
549:
538:
514:. Retrieved
507:
498:
445:invented by
438:skin lesions
381:
375:
365:
356:
355:
327:
286:
264:
252:
251:
231:
161:Headquarters
97:Company type
66:
57:
42:by removing
38:Please help
30:
1398:Electronics
1359:MIND C.T.I.
1047:28 November
1015:28 November
965:28 November
939:28 November
903:28 November
877:28 November
827:28 November
794:28 November
761:28 November
730:21 February
630:28 November
600:28 November
572:28 November
516:28 November
378:development
310:Hepatitis C
275:and on the
246:Har Hotzvim
1528:Categories
1248:AudioCodes
1167:Healthcare
1081:8 February
491:References
366:Ramius LLC
344:Operations
324:Management
222:.biolinerx
178:Key people
60:April 2021
40:improve it
1425:SolarEdge
1293:Radvision
1263:DSP Group
1179:BioLineRx
1009:Bloomberg
959:Israel21c
898:Jerusalem
871:Jerusalem
751:ISRAEL21c
594:TheMarker
382:BioLineRx
357:BioLineRx
109:Traded as
1420:Orbotech
1344:CyberArk
1339:Cimatron
1312:Software
1303:RR Media
1243:Alvarion
1231:Networks
1190:Compugen
1184:BiondVax
680:Archived
655:27 April
607:history.
474:See also
464:protease
372:Pipeline
314:Novartis
208:Novartis
194:Services
133:Industry
1513:Isramco
1446:Arotech
1374:Radware
1174:Alcobra
981:"Other"
686:30 June
676:Reuters
449:of the
395:BL-1020
267:, is a
265:BioLine
215:Website
151: (
143:Founded
125::
117::
1349:Jacada
1288:Radcom
1153:Nasdaq
928:Globes
816:Globes
783:Globes
512:. 2011
332:, was
263:), or
257:Hebrew
204:Owners
171:Israel
166:Modiin
115:Nasdaq
101:Public
1205:Pluri
318:stake
1405:CEVA
1083:2012
1049:2011
1017:2011
967:2011
941:2011
905:2011
879:2011
829:2011
796:2011
763:2011
732:2015
688:2017
657:2019
632:2011
602:2011
574:2011
518:2011
429:CB2R
399:GABA
305:ADRs
289:Teva
224:.com
153:2003
146:2003
127:BLRX
123:TASE
119:BLRX
1389:Wix
380:by
334:CEO
301:NIS
220:www
187:CEO
1530::
1069:.
1065:.
1033:.
1006:.
983:.
957:.
925:.
869:.
863:.
813:.
780:.
749:.
723:.
678:.
674:.
634:.
623:.
604:.
591:.
558:.
526:^
506:.
368:.
279:.
259::
169:,
1137:e
1130:t
1123:v
1085:.
1051:.
1019:.
969:.
943:.
911:.
881:.
831:.
798:.
765:.
734:.
690:.
659:.
520:.
255:(
189:)
185:(
155:)
73:)
67:(
62:)
58:(
54:.
36:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
